Clinical Trial Update: Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing microwave ablation plus camrelizumab versus camrelizumab alone in metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Microwave ablation (microwave ablation)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: NSCLC Stage IV | Phase 2 | Status: UNKNOWN